You know your body. If something doesn’t feel right, get help.
If one provider dismisses you, contact another provider. Go to an Urgent Care.
If your periods are irregular, and you have any suspicion that you may be pregnant, don’t wait! You may get a free pregnancy test from your local Planned Pregnancy clinic. Give them a call.
A U.S. study found that a combination of estrogen and progesterone hormone supplements does not increase the risk of ovarian or uterine cancer in a diverse group of menopausal women.
have or have had certain cancers such as breast cancer or uterine cancer
have or have had blood clots in the legs or lungs
have a bleeding disorder
have had a stroke or heart attack
have liver problems
have serious reactions to estrogen medicines
think you are pregnant
Serious Side Effects
Heart attack or stroke
Blood clots
Breast Cancer
Dementia in women 65 years and older
Gallbladder disease or high triglyceride (cholesterol) levels that could lead to problems with your pancreas
Vision loss caused by a blood clot in the eye
Liver problems
High blood pressure
Severe allergic reactions
Less Serious, Common Side Effects
Headaches
Painful or tender breasts
Vaginal spotting
Stomach cramps/bloating
Nausea and vomiting
Hair loss
Fluid retention
Vaginal yeast infection
“ The study conducted in 40 U.S. clinics between 1993-1998 looked at 27,347 postmenopausal women aged 50 to 79 who had no cancer history in the past decade, with about 20% from minority groups. Around 60.7% still had a uterus, and 39.3% had a hysterectomy. Women were given either conjugated equine estrogen or conjugated equine estrogen plus medroxyprogesterone acetate or a placebo. After 20 years, women on conjugated equine estrogen alone had twice the risk of ovarian cancer and nearly three times the risk of dying from it compared to the placebo group. Women on conjugated equine estrogen plus medroxyprogesterone acetate had no higher risk of ovarian cancer but showed a reduced risk of endometrial cancer and death from it (Rowan T. Chlebowski, MD, PhD, chief of the division of medical oncology and hematology at Harbor-UCLA Medical Center and investigator at The Lundquist Institute)”